Back to School: How biopharma can reboot drug development. Access exclusive analysis here

OSI, DNA start Tarceva Phase IIIb

OSIP and Genentech (DNA) began the open-label, Phase IIIb ACT

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE